Detalhe da pesquisa
1.
Tixagevimab/cilgavimab (AZD7442/Evusheld) prevent from COVID19 in patients with hematologic malignancies under active chemotherapy.
Ann Hematol
; 2024 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38678486
2.
Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study.
Mol Cancer
; 22(1): 200, 2023 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38066564
3.
A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.
Am J Gastroenterol
; 118(8): 1373-1380, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36728217
4.
Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015).
Ann Hematol
; 102(8): 2233-2240, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37392367
5.
Risk factors of menopause after allogeneic hematopoietic cell transplantation in premenopausal adult women.
Eur J Haematol
; 111(3): 449-457, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37308461
6.
The soluble VCAM-1 level is a potential biomarker predicting severe acute graft versus host disease after allogeneic hematopoietic cell transplantation.
BMC Cancer
; 22(1): 997, 2022 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36127634
7.
Clinicopathologic Characteristics Associated with Prognosis in Ocular Extranodal Marginal Zone B Cell Lymphoma.
Medicina (Kaunas)
; 58(6)2022 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35744081
8.
Busulfan, etoposide, cytarabine, and melphalan as a high-dose regimen for autologous stem cell transplantation in peripheral T-cell lymphomas.
Ann Hematol
; 100(1): 189-196, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33205337
9.
Carfilzomib in addition to lenalidomide and dexamethasone in Asian patients with RRMM outside of a clinical trial.
Ann Hematol
; 100(8): 2051-2059, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33447888
10.
Second allogeneic hematopoietic stem cell transplantation in patients with acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation.
Clin Transplant
; 35(3): e14199, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33349948
11.
Multicenter phase III trial of S-1 and cisplatin versus S-1 and oxaliplatin combination chemotherapy for first-line treatment of advanced gastric cancer (SOPP trial).
Gastric Cancer
; 24(1): 156-167, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32596783
12.
Late complications and quality of life assessment for survivors receiving allogeneic hematopoietic stem cell transplantation.
Support Care Cancer
; 29(2): 975-986, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32556712
13.
Pegteograstim prophylaxis for chemotherapy-induced neutropenia and febrile neutropenia: a prospective, observational, postmarketing surveillance study in Korea.
Support Care Cancer
; 29(9): 5383-5390, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33683460
14.
Changes in decision-making process for life-sustaining treatment in patients with advanced cancer after the life-sustaining treatment decisions-making act.
BMC Palliat Care
; 20(1): 63, 2021 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33906659
15.
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death.
BMC Cancer
; 20(1): 1193, 2020 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33276759
16.
CD45dimCD34+CD38-CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia.
BMC Cancer
; 20(1): 285, 2020 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32252668
17.
Phase II study of safety and efficacy of BEB (bendamustine, etoposide, and busulfan) conditioning regimen for autologous stem cell transplantation in non-Hodgkin lymphoma.
Ann Hematol
; 99(4): 819-828, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32025840
18.
Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report.
Ann Hematol
; 99(2): 223-228, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31853704
19.
A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin's lymphoma.
Ann Hematol
; 99(2): 255-264, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31897676
20.
The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study).
Ann Hematol
; 99(2): 309-319, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31872360